Edition:
United States

RTI Surgical Inc (RTIX.OQ)

RTIX.OQ on NASDAQ Stock Exchange Global Select Market

4.60USD
4:00pm EDT
Change (% chg)

$-0.05 (-1.08%)
Prev Close
$4.65
Open
$4.65
Day's High
$4.65
Day's Low
$4.55
Volume
20,093
Avg. Vol
58,904
52-wk High
$6.00
52-wk Low
$2.50

Chart for

About

RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company's business primarily consists of six categories, such as spine,... (more)

Overall

Beta: 1.73
Market Cap(Mil.): $276.72
Shares Outstanding(Mil.): 59.51
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.51 16.34
EPS (TTM): -- -- --
ROI: -- 13.78 14.66
ROE: -- 16.61 14.00

BRIEF-RTI names Jonathon Singer as Chief Financial and Administrative Officer​

* RTI Surgical continues to augment leadership team to accelerate its strategic direction

Sep 18 2017

BRIEF-RTI Surgical Inc enters into a third amended and restated loan agreement​

* RTI Surgical Inc says ‍on August 3, 2017 company entered into a third amended and restated loan agreement​ - SEC filing

Aug 09 2017

BRIEF-RTI Surgical posts Q2 loss of $0.04 per share

* Sees FY 2017 adjusted earnings per share $0.04 to $0.08 excluding items

Aug 08 2017

BRIEF-RTI Surgical divests cardiothoracic closure business to A&E Medical Corp

* RTI Surgical divests cardiothoracic closure business to A&E Medical Corporation for up to $60 million

Aug 03 2017

BRIEF-RTI Surgical Q1 revenue $69.9 million

* Sees fy 2017 adjusted earnings per share $0.05 to $0.10 excluding items

Apr 27 2017

BRIEF-RTI Surgical expands line of tissue matrices in international markets

* Announces expansion of its extensive line of tissue matrices in international markets Source text for Eikon: Further company coverage:

Apr 18 2017

Earnings vs. Estimates